Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), a phosphorylation- and ATP-regulated anion channel. CFTR expression and activity is frequently associated with an anion exchanger (AE) such as AE2 coded by the Slc4a2 gene. Mice null for Cftr and mice null for Slc4a2 have enamel defects, and there are some case reports of enamel anomalies in patients with CF. In this study we demonstrate that both Cftr and AE2 expression increased significantly during the rat enamel maturation stage versus the earlier secretory stage (5.6- and 2.9-fold, respectively). These qPCR data im- ply that there is a greater demand for Cl– and bicarbonate (HCO3–) transport during the maturation stage of enamel formation, and that this is, at least in part, provided by changes in Cftr and AE2 expression. In addition, the enamel phenotypes of 2 porcine models of CF, CFTR- null, and CFTR- ΔF508 have been examined using backscattered electron microscopy in a scanning electron microscope. The enamel of newborn CFTR- null and CFTR- ΔF508 animals is hypomineralized. Together, these data provide a molecular basis for interpreting enamel disease associated with disruptions to CFTR and AE2 expression.

Keywords:
Cystic fibrosis, Dental, Enamel, Hydroxyapatite
1.
Arquitt, C.K., C. Boyd, J.T. Wright (2002) Cystic fibrosis transmembrane regulator gene (CFTR) is associated with abnormal enamel formation. J Dent Res 81: 492–496.
2.
Atar, M., E.J. Korperich (2010) Systemic disorders and their influence on the development of dental hard tissues: a literature review. J Dent 38: 296–306.
3.
Azevedo, T.D., G.C. Feijo, A.C. Bezerra (2006) Presence of developmental defects of enamel in cystic fibrosis patients. J Dent Child (Chic) 73: 159–163.
4.
Banales, J.M., T.V. Masyuk, P.S. Bogert, B.Q. Huang, S.A. Gradilone, S.O. Lee, A.J. Stroope, A.I. Masyuk, J.F. Medina, N.F. LaRusso (2008) Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease. Am J Pathol 173: 1637–1646.
5.
Bivin, W.S., R.C. McClure (1976) Deciduous tooth chronology in the mandible of the domestic pig. J Dent Res 55: 591–597.
6.
Bronckers, A., L. Kalogeraki, H.J. Jorna, M. Wilke, T.J. Bervoets, D.M. Lyaruu, B. Zandieh-Doulabi, P. Denbesten, H. de Jonge (2010) The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells. Bone 46: 1188–1196.
7.
Gawenis, L.R., C. Ledoussal, L.M. Judd, V. Prasad, S.L. Alper, A. Stuart-Tilley, A.L. Woo, C. Grisham, L.P. Sanford, T. Doetschman, M.L. Miller, G.E. Shull (2004) Mice with a targeted disruption of the AE2 Cl-/HCO3-exchanger are achlorhydric. J Biol Chem 279: 30531–30539.
8.
Hu, J.C., C. Zhang, X. Sun, Y. Yang, X. Cao, O. Ryu, J.P. Simmer (2000) Characterization of the mouse and human PRSS17 genes, their relationship to other serine proteases, and the expression of PRSS17 in developing mouse incisors. Gene 251: 1–8.
9.
Josephsen, K., Y. Takano, S. Frische, J. Praetorius, S. Nielsen, T. Aoba, O. Fejerskov (2010) Ion transporters in secretory and cyclically modulating ameloblasts: a new hypothesis for cellular control of preeruptive enamel maturation. Am J Physiol Cell Physiol 299: C1299–C1307.
10.
Lacruz, R.S., A. Nanci, I. Kurtz, J.T. Wright, M.L. Paine (2010a) Regulation of pH during amelogenesis. Calcif Tissue Int 86: 91–103.
11.
Lacruz, R.S., A. Nanci, S.N. White, X. Wen, H. Wang, S.F. Zalzal, V.Q. Luong, V.L. Schuetter, P.S. Conti, I. Kurtz, M.L. Paine (2010b) The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition. J Biol Chem 285: 24432–24438.
12.
Livak, K.J., T.D. Schmittgen (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402–408.
13.
Lyaruu, D.M., A.L. Bronckers, L. Mulder, P. Mardones, J.F. Medina, S. Kellokumpu, R.P. Oude Elferink, V. Everts (2008) The anion exchanger Ae2 is required for enamel maturation in mouse teeth. Matrix Biol 27: 119–127.
14.
Moffatt, P., C.E. Smith, R. St-Arnaud, A. Nanci (2008) Characterization of Apin, a secreted protein highly expressed in tooth-associated epithelia. J Cell Biochem 103: 941–956.
15.
Narang, A., A. Maguire, J.H. Nunn, A. Bush (2003) Oral health and related factors in cystic fibrosis and other chronic respiratory disorders. Arch Dis Child 88: 702–707.
16.
Paine, M.L., M.L. Snead, H.J. Wang, N. Abuladze, A. Pushkin, W. Liu, L.Y. Kao, S.M. Wall, Y.H. Kim, I. Kurtz (2008) Role of NBCe1 and AE2 in secretory ameloblasts. J Dent Res 87: 391–395.
17.
Rogers, C.S., D.A. Stoltz, D.K. Meyerholz, L.S. Ostedgaard, T. Rokhlina, P.J. Taft, M.P. Rogan, A.A. Pezzulo, P.H. Karp, O.A. Itani, A.C. Kabel, C.L. Wohlford-Lenane, G.J. Davis, R.A. Hanfland, T.L. Smith, M. Samuel, D. Wax, C.N. Murphy, A. Rieke, K. Whitworth, A. Uc, T.D. Starner, K.A. Brogden, J. Shilyansky, P.B. McCray Jr., J. Zabner, R.S. Prather, M.J. Welsh (2008) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321: 1837–1841.
18.
Sasaki, S., T. Takagi, M. Suzuki (1991) Cyclical changes in pH in bovine developing enamel as sequential bands. Arch Oral Biol 36: 227–231.
19.
Shumaker, H., H. Amlal, R. Frizzell, C.D. Ulrich 2nd, M. Soleimani (1999) CFTR drives Na+-nHCO-3 cotransport in pancreatic duct cells: a basis for defective HCO-3 secretion in CF. Am J Physiol 276: C16–C25.
20.
Smith, C.E. (1998) Cellular and chemical events during enamel maturation. Crit Rev Oral Biol Med 9: 128–161.
21.
Smith, C.E., A. Nanci (1989) A method for sampling the stages of amelogenesis on mandibular rat incisors using the molars as a reference for dissection. Anat Rec 225: 257–266.
22.
Smith, C.E., A. Nanci, P. Moffatt (2006) Evidence by signal peptide trap technology for the expression of carbonic anhydrase 6 in rat incisor enamel organs. Eur J Oral Sci 114(suppl 1): 147–153, discussion 164–145, 380–141.
23.
Snouwaert, J.N., K.K. Brigman, A.M. Latour, N.N. Malouf, R.C. Boucher, O. Smithies, B.H. Koller (1992) An animal model for cystic fibrosis made by gene targeting. Science 257: 1083–1088.
24.
Stoltz, D.A., D.K. Meyerholz, A.A. Pezzulo, S. Ramachandran, M.P. Rogan, G.J. Davis, R.A. Hanfland, C. Wohlford-Lenane, C.L. Dohrn, J.A. Bartlett, G.A. Nelson 4th, E.H. Chang, P.J. Taft, P.S. Ludwig, M. Estin, E.E. Hornick, J.L. Launspach, M. Samuel, T. Rokhlina, P.H. Karp, L.S. Ostedgaard, A. Uc, T.D. Starner, A.R. Horswill, K.A. Brogden, R.S. Prather, S.S. Richter, J. Shilyansky, P.B. McCray Jr., J. Zabner, M.J. Welsh (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2: 29ra31.
25.
Sui, W., C. Boyd, J.T. Wright (2003) Altered pH regulation during enamel development in the cystic fibrosis mouse incisor. J Dent Res 82: 388–392.
26.
Takagi, T., T. Ogasawara, J. Tagami, M. Akao, Y. Kuboki, N. Nagai, R.Z. LeGeros (1998) pH and carbonate levels in developing enamel. Connect Tissue Res 38: 181–187; discussion 201–205.
27.
Wright, J.T., C.L. Kiefer, K.I. Hall, B.R. Grubb (1996) Abnormal enamel development in a cystic fibrosis transgenic mouse model. J Dent Res 75: 966–973.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.